Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2007-9-10
pubmed:abstractText
Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression is analyzed in Swedish melanoma patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0171-5216
pubmed:author
pubmed:issnType
Print
pubmed:volume
133
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
859-66
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17492467-Adult, pubmed-meshheading:17492467-Aged, pubmed-meshheading:17492467-Aged, 80 and over, pubmed-meshheading:17492467-Case-Control Studies, pubmed-meshheading:17492467-DNA-Binding Proteins, pubmed-meshheading:17492467-Female, pubmed-meshheading:17492467-Genetic Predisposition to Disease, pubmed-meshheading:17492467-Genotype, pubmed-meshheading:17492467-Humans, pubmed-meshheading:17492467-I-kappa B Proteins, pubmed-meshheading:17492467-Male, pubmed-meshheading:17492467-Melanoma, pubmed-meshheading:17492467-Middle Aged, pubmed-meshheading:17492467-NF-kappa B p50 Subunit, pubmed-meshheading:17492467-Phenotype, pubmed-meshheading:17492467-Polymerase Chain Reaction, pubmed-meshheading:17492467-Polymorphism, Genetic, pubmed-meshheading:17492467-Polymorphism, Restriction Fragment Length, pubmed-meshheading:17492467-Promoter Regions, Genetic, pubmed-meshheading:17492467-Skin Neoplasms, pubmed-meshheading:17492467-Sunlight, pubmed-meshheading:17492467-Sweden
pubmed:year
2007
pubmed:articleTitle
Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients.
pubmed:affiliation
Department of Dermatology, Institute of Biomedicine and Surgery, Linköping University, 581 85, Linköping, Sweden.
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't